文献
J-GLOBAL ID:201802272116324825
整理番号:18A0751048
Ino-Vateで登録された再発または難治性急性リンパ芽球性白血病患者におけるイノツzumabゾガマイシンの年齢コホートによる有効性および安全性分析【JST・京大機械翻訳】
Efficacy and safety analysis by age cohort of inotuzumab ozogamicin in patients with relapsed or refractory acute lymphoblastic leukemia enrolled in INO-VATE
著者 (13件):
Jabbour Elias J.
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
DeAngelo Daniel J.
(Department of Medical Oncology/Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Stelljes Matthias
(Department of Internal Medicine, University of Muenster, Muenster, Germany)
,
Stock Wendy
(Department of Hematology/Oncology, University of Chicago, Chicago, Illinois)
,
Liedtke Michaela
(Divisions of Hematology and Oncology, Stanford Cancer Institute, Stanford, California)
,
Gokbuget Nicola
(Department of Medicine, Goethe University, Frankfurt, Germany)
,
O’Brien Susan
(Division of Hematology/Oncology, University of California Irvine, Orange, California)
,
Wang Tao
(Pfizer, Inc, Groton, Connecticut)
,
Paccagnella M. Luisa
(Pfizer, Inc, Groton, Connecticut)
,
Sleight Barbara
(Pfizer, Inc, Groton, Connecticut)
,
Vandendries Erik
(Pfizer Inc, Cambridge, Massachusetts)
,
Advani Anjali S.
(Department of Medical Oncology/Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Kantarjian Hagop M.
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
資料名:
Cancer (Hoboken, N.J.)
(Cancer (Hoboken, N.J.))
巻:
124
号:
8
ページ:
1722-1732
発行年:
2018年
JST資料番号:
D0781B
ISSN:
0008-543X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)